Nonalcoholic Steatohepatitis (NASH) ages 18+
PMG Research of Winston Salem
A research study is evaluating an investigational medication for patients with Nonalcoholic Steatohepatitis (NASH).
This research study may be an option if you:
• Have a confirmed diagnosis of cirrhosis due to NASH based upon prior liver biopsy
• Are suspected to have cirrhosis due to NASH and are willing to undergo a liver biopsy as part of the study to confirm diagnosis
Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you. Learn more about NASH and what might put you at risk, visit www.pmg-research.com/NASH.
Qualified participants will receive all study-related care at no cost.
Patient Commitment Duration
Approximately 27 months including an optional open-label extension
Financial compensation may be provided for time and travel expenses.
Number of visits in study
Approximately 19 clinic visits including an optional open-label extension